| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 24.05.
| Boston CEO Conference to Feature CEOs of Alkermes, Alnylam, Ariad, Biogen, Cubist, Genzyme, Millennium, Momenta, Sirtris, and Others June 11th and 12th | | 59 | Business Wire |
| More than 200 leading CEOs will gather at the 2012 CEO Conference June 11th
and 12th at the Mandarin Oriental Hotel in Boston.
The Boston CEO Conference is...
Mehr lesen zu:
Boston CEO Conference to Feature CEOs of Alkermes, Alnylam, Ariad, Biogen, Cubist, Genzyme, Millennium, Momenta, Sirtris, and Others June 11th and 12th | |
| 23.05.
| Momenta Pharmaceuticals Down 16.1% Since SmarTrend Downtrend Call | | - | SmarTrend |
| 22.05.
| Has Momenta Pharmaceuticals Become the Perfect Stock? | | 1 | Motley Fool |
| 15.05.
| Downtrend Call Working As Momenta Pharmaceuticals Stock Falls 15.4% | | 1 | SmarTrend |
| 10.05.
| Momenta Pharmaceuticals is Among the Companies in the Biotechnology Industry With the Lowest EV/EBITDA Ratio | | 2 | SmarTrend |
| 08.05.
| Momenta Pharmaceuticals Down 17.2% Since SmarTrend Downtrend Call | | 1 | SmarTrend |
| 03.05.
| Momenta Pharmaceuticals' CEO Discusses Q1 2012 Results - Earnings Call Transcript | | 4 | Seeking Alpha |
| 03.05.
| Momenta Pharmaceuticals Crosses Below its 10-day MA | | - | SmarTrend |
| 20.04.
| Shares of Momenta Pharmaceuticals Rank the Lowest in Terms of P/E Ratio in the Biotechnology Industry | | - | SmarTrend |
| 19.04.
| Notable Options Activity in Momenta Pharmaceuticals Inc | | 2 | Benzinga.com |
| 19.04.
| Momenta Pharmaceuticals Crosses Above its 10-day MA | | - | SmarTrend |
| 11.04.
| Lowest EV/EBITDA Ratio in the Biotechnology Industry Detected in Shares of Momenta Pharmaceuticals | | 1 | SmarTrend |
| 02.04.
| Momenta Pharmaceuticals Bullish Moving Average Crossover Alert | | 1 | SmarTrend |
| 12.03.
| Momenta Pharmaceuticals and Sunpeaks Ventures Making Headway in Lucrative Anticoagulant Market / SNPK is on Today's Volume Watchlist | | 24 | MarketWire |
| LONDON, ENGLAND -- (Marketwire) -- 03/12/12 -- The US leader in micro cap alerts offers its high quality stocks alert newsletter to investors looking for the best picks around!
SNPK (Sunpeaks...
Mehr lesen zu:
Momenta Pharmaceuticals and Sunpeaks Ventures Making Headway in Lucrative Anticoagulant Market / SNPK is on Today's Volume Watchlist | |
| 12.03.
| Momenta Pharmaceuticals and Sunpeaks Ventures Making Headway in Lucrative Anticoagulant Market / Five Star Equities Provides Stock Research on Momenta Pharmaceuticals & Sunpeaks Ventures | | 49 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 03/12/12 -- The anticoagulant market continues to skyrocket as an aging population requires prevention from stroke and systemic embolism. While Warfarin has long dominated...
Mehr lesen zu:
Momenta Pharmaceuticals and Sunpeaks Ventures Making Headway in Lucrative Anticoagulant Market / Five Star Equities Provides Stock Research on Momenta Pharmaceuticals & Sunpeaks Ventures | |
| 15.02.
| A Forward Look, The Year Ahead - Featured Research on Momenta Pharmaceuticals, Inc. and Cubist Pharmaceuticals Inc | | 11 | MarketWire |
| HONG KONG -- (Marketwire) -- 02/15/12 -- Today, www.BollingerReport.com introduced featured coverage of Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) and Cubist Pharmaceuticals Inc (NASDAQ: CBST). Full...
Mehr lesen zu:
A Forward Look, The Year Ahead - Featured Research on Momenta Pharmaceuticals, Inc. and Cubist Pharmaceuticals Inc | |
| 30.01.
| Momenta Pharmaceuticals (MNTA) Replaces HealthSpring (HS) in S&P SmallCap 600 | | 3 | StreetInsider.com |
| 26.01.
| Momenta (MNTA) Reports Court Grants Watson, Amphastar Preliminary Injunction | | 3 | StreetInsider.com |
| 26.01.
| Zacks Releases Four Powerful 'Buy' Stocks: Momenta Pharmaceuticals, Lowe's Companies, Humana and Energy Partners Limited | | 16 | PR Newswire |
| CHICAGO, Jan. 25, 2012 /PRNewswire/ -- Four free stock picks are being made available today on Zacks.com. The industry's leading independent research firm highlights one Zacks #1 Rank...
Mehr lesen zu:
Zacks Releases Four Powerful 'Buy' Stocks: Momenta Pharmaceuticals, Lowe's Companies, Humana and Energy Partners Limited | |
| 22.12.
| Baxter (BAX), Momenta (MNTA) Enter Global Biosimilar Development Collaboration | | 2 | StreetInsider.com |
